PepGen Inc reports results for the quarter ended September 30 - Earnings Summary

* PepGen Inc  PEPG.OQ  reported a quarterly adjusted loss
of 66
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -98 cents.  The mean expectation of five analysts for the
quarter was for a loss of 87 cents per share. Wall Street
expected results to range from -98 cents to -64 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PepGen Inc's reported EPS for the quarter was a loss of 66
cents​.
    * The company reported a quarterly loss of $21.38 million.
    * PepGen Inc shares had fallen by 34.2% this quarter and
lost 17.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for PepGen Inc is
17.00 
This summary was machine generated from LSEG data November 8 at
04:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.87          -0.66          Beat
 Jun. 30 2024      -0.72          -0.87          Missed
 Mar. 31 2024      -0.74          -0.63          Beat
 Dec. 31 2023      -1.01          -0.81          Beat

Recent news on PepGen

See all news